These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21757053)

  • 1. Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation.
    Huq FY; Tvarkova K; Arafa A; Kadir RA
    Contraception; 2011 Aug; 84(2):128-32. PubMed ID: 21757053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of menstrual flow by weighing protective pads in women with normal, decreased or increased menstruation.
    Gudmundsdottir BR; Hjaltalin EF; Bragadottir G; Hauksson A; Geirsson RT; Onundarson PT
    Acta Obstet Gynecol Scand; 2009; 88(3):275-9. PubMed ID: 19137461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measured menstrual blood loss in women with a bleeding disorder or using oral anticoagulant therapy.
    van Eijkeren MA; Christiaens GC; Haspels AA; Sixma JJ
    Am J Obstet Gynecol; 1990 May; 162(5):1261-3. PubMed ID: 2339725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorders of menstruation and their effect on the quality of life in women with congenital factor VII deficiency.
    Kulkarni A; Lee CA; Griffeon A; Kadir RA
    Haemophilia; 2006 May; 12(3):248-52. PubMed ID: 16643209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of idiopathic menorrhagia with tranexamic acid.
    Srinil S; Jaisamrarn U
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S1-6. PubMed ID: 17722310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A multicenter prospective randomized open comparative study on the treatment of ovulatory menorrhagia with tranexamic acid and norethisterone in China].
    Zhang YW; He FF; Sun ZY; Li SW; Bi SL; Huang XL; Cao ZS; Lü SL; Lu JL; Zhang ZY; Zhu YM; Huang HF; Miao MH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):247-50. PubMed ID: 18843961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting of lactation and normal menstrual information by Papua New Guinean women.
    Mola GL; Amoa AB
    P N G Med J; 1999; 42(3-4):71-2. PubMed ID: 11428498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of hormonal contraceptives in an institutional setting: reasons for use, consent and safety in women with psychiatric and intellectual disabilities.
    Egan TM; Siegert RJ; Fairley NA
    N Z Med J; 1993 Aug; 106(961):338-41. PubMed ID: 8341476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A; Wildemeersch D
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of warfarin on menstruation and menstrual management of the adolescent on warfarin.
    Peake LJ; Grover SR; Monagle PT; Kennedy AD
    J Paediatr Child Health; 2011 Dec; 47(12):893-7. PubMed ID: 21658146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin.
    Zakherah MS; Sayed GH; El-Nashar SA; Shaaban MM
    Gynecol Obstet Invest; 2011; 71(4):281-4. PubMed ID: 21228538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current monophasic hormonal contraception].
    Chernev T; Ivanov S; Sirakov M
    Akush Ginekol (Sofiia); 1998; 37(2):9-11. PubMed ID: 9859526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.